Overview of Dr. Caskey
Dr. Marina Caskey is an infectious disease specialist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and New York-Presbyterian Hospital. She received her medical degree from Other and has been in practice 19 years. She is one of 142 doctors at New York-Presbyterian Hospital and one of 142 doctors at New York-Presbyterian Hospital who specialize in Infectious Disease. She has more than 70 publications and over 500 citings.
Office
525 E 68th St
Room A421
New York, NY 10021Fax+1 212-746-8675
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 2003 - 2006
- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2000 - 2003
- OtherClass of 1998
Certifications & Licensure
- NY State Medical License 2003 - 2025
Clinical Trials
- Study to Evaluate the Safety and Immunogenicity of Poly ICLC (Hiltonol) in Healthy Volunteers Start of enrollment: 2009 Nov 01
- Polyinosinic-Polycytidylic Acid-poly-L-lysine Carboxymethylcellulose (Poly-ICLC) in Healthy Volunteers Start of enrollment: 2011 Jun 01
- A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117 Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 71 citationsReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens.Colin R. Zamecnik, Jayant V. Rajan, Kevin A. Yamauchi, Sabrina A Mann, Rita P. Loudermilk
Cell Reports. Medicine. 2020-10-20 - 936 citationsEvolution of antibody immunity to SARS-CoV-2.Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, Frauke Muecksch, Shlomo Finkin
Nature. 2021-01-18 - 585 citationsViraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Marina Caskey, Florian Klein, Julio C. C. Lorenzi, Michael S. Seaman, Anthony P. West
Nature. 2015-06-25
Journal Articles
- Relationship Between Intact HIV-1 Proviruses in Circulating CD4+ T Cells and Rebound Viruses Emerging During Treatment InterruptionMichel C Nussenzweig, Thiago Y Oliveira, Marina Caskey, Proceedings of the National Academy of Sciences
- Combination Therapy with Anti-HIV-1 Antibodies Maintains Viral SuppressionMichael S Seaman, Katrina Millard, Marina Caskey, Michel C Nussenzweig, Roy M Gulick, Thiago Y Oliveira, Nature
- Safety and Antiviral Activity of Combination HIV-1 Broadly Neutralizing Antibodies in Viremic IndividualsRoy M Gulick, Thiago Y Oliveira, Marina Caskey, Michel C Nussenzweig, Michael S Seaman, Katrina Millard, Nature
Press Mentions
- How Close Are We to a Cure for HIV?July 6th, 2019
- New Therapy May Control HIV Without Daily PillsOctober 26th, 2018
- HIV Cure May Lie in Novel Immunotherapy TreatmentSeptember 28th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: